This book chapter advances SDGs 3 and 17 by reviewing how to diagnosis mixed dementias.
This book chapter advances SDGs 3 and 17 by reviewing pathological and functional outcomes of both preventative and therapeutic environmental enrichment on commonly used mouse models of amyloid pathology.
This book chapter advances SDGs 3 and 17 by discussing the potential impact of dementia on creativity, physical activity, and exercise participation and whether exercise and creativity may each exert individual effects on the maintenance and/or facilitation of cognitive health. This chapter explores the context of biological and theoretical mechanisms underlying dementia and provide recommendations for future research experiments unifying physical exercise and creative activities into tailored interventions designed to better comprehend this disease and perhaps counteract the devastating implications dementia prognoses present to optimal physical and mental functioning across the human life span.
This book chapter advances SDGs 3 and 17 by describing how acute hospital settings can affect the care of patients with dementia. As well as changes to the physical hospital environment, this requires an enhanced focus on key strategies such as reliable identification of cognitive impairment, access to comprehensive geriatric assessment, prevention and management of delirium, and timely discharge planning are included in the chapter.
This book chapter advances SDGs 3 and 17 by discussing available data regarding the effects of genetic variants on the clinical and pathological characteristics of “frontotemporal dementia” (FTD). The term “frontotemporal dementia” (FTD) defines a group of related diseases resulting from progressive degeneration of the temporal and frontal lobes. These areas play a significant role in decision-making, behavioral control, emotion, language, and motor functions.
This book chapter advances SDGs 3 and 17 by focusing on providing a brief overview of genes associated with sporadic (late-onset) Alzheimer's disease (AD). Despite decades of research, no current and reliable test is currently available for the diagnosis of AD. Genetic biomarkers are promising for both diagnostic tools and tailored profiling therapy.
This book chapter advances SDG 11, 13, 17 by describing the Intergovernmental Panel on Climate Change and other reports on the need to limit global temperature increase to 2.0°C and preferably 1.5°C. The chapter outlines possible scenarios and introduces the concept of “net zero” by 2050, the essential elimination of greenhouse gas emissions. The chapter also discusses why this deadline is not achievable and presents a more likely scenario.
The new 2030 sustainable development agenda is likely to dominate policy and academic debates at both national and international levels over next 15 years and beyond.
Purpose: Given incomplete data reporting by race, we used data on COVID-19 cases and deaths in U.S. counties to describe racial disparities in COVID-19 disease and death and associated determinants.
The sixth RELX SDG Inspiration Day took place on Wednesday 24 June 2020 with nearly 400 representatives from business, NGOs, academia and civil society. The Inspiration Day gave hope that, although the pandemic has created significant barriers to meeting the SDGs by 2030, global collaboration is our best bet for overcoming them.
